LAB International intents to acquire PharmaForm

30-Oct-2006

LAB International Inc. announced it has signed a non-binding letter of intent ("LOI") to acquire all of the outstanding membership interests of PharmaForm L.L.C.. The closing of this transaction is subject to the completion of satisfactory due diligence, the negotiation of a definitive purchase and sale agreement, regulatory and Board approval. The closing of the transaction is anticipated to take place on or before December 1, 2006.

Consideration for the acquisition is U.S $7.5 million payable in cash and $4.375 million in LAB shares at closing. PharmaForm shareholders are eligible for additional payments in LAB shares upon completion of certain milestones related to pipeline products in PharmaForm's drug development programs reaching specific clinical trial stages.

"The acquisition of PharmaForm is central to our corporate strategy of becoming an integrated specialty Pharma and pain management Company. It will add complementary platforms and products to our pipeline which will soon be entering clinical trial stages. It will also ensure manufacturing capabilities of Fentanyl TAIFUN® in the U.S., provide us the flexibility to streamline our LAB Pharma unit by leveraging operational synergies and greatly enhance our management and scientific expertise." commented Dr. Halvor Jaeger, CEO of LAB International.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Changes in the leadership team of Performance Materials - Merck announced another milestone of its transformation program “Bright Future” for the business sector Performance Materials

Changes in the leadership team of Performance Materials - Merck announced another milestone of its transformation program “Bright Future” for the business sector Performance Materials

Consortium combines strengths to further develop innovative OLED lighting systems - Joint project “TOPAS 2012” develops lighting technology of the future based on organic light-emitting diodes

Need entangled atoms? - Get 'Em FAST! with NIST's new patent-pending method

Need entangled atoms? - Get 'Em FAST! with NIST's new patent-pending method

High-Tech Gründerfonds starts lining up investments for HTGF III fund - Seed-stage investor announces first investments from third fund

New adsorption process makes headway in the United States - Iron hydroxide proves to be a highly effective adsorbent

Makhteshim Agan Industries launches another three important herbicides in the U.S.A. corn market

AkzoNobel to invest in organic peroxide operations in the US and Europe

Frost & Sullivan recognizes BASF’s transformation - BASF showcases its multi-pronged success with a variety of interactive components and its own line of coatings

Chlorinated solvents market not yet fully recovered from economic climate - Perchloroethylene sales remained stable while Methylene Chloride went further down

Favorable Visudyne clinical results announced for occult AMD and pathologic myopia patients

Miniature X-ray source using wiggling electrons

Miniature X-ray source using wiggling electrons

LBBC Technologies - Leeds, United Kingdom

LBBC Technologies - Leeds, United Kingdom